Cargando…
Ligand modified nanoparticles increases cell uptake, alters endocytosis and elevates glioma distribution and internalization
Nanoparticles (NPs) were widely used in drugs/probes delivery for improved disease diagnosis and/or treatment. Targeted delivery to cancer cells is a highly attractive application of NPs. However, few studies have been performed on the targeting mechanisms of these ligand-modified delivery systems....
Autores principales: | Gao, Huile, Yang, Zhi, Zhang, Shuang, Cao, Shijie, Shen, Shun, Pang, Zhiqing, Jiang, Xinguo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3755284/ https://www.ncbi.nlm.nih.gov/pubmed/23982586 http://dx.doi.org/10.1038/srep02534 |
Ejemplares similares
-
CORRIGENDUM: Ligand modified nanoparticles increases cell uptake, alters endocytosis and elevates glioma distribution and internalization
por: Gao, Huile, et al.
Publicado: (2014) -
Role of Ligand Distribution in the Cytoskeleton-Associated Endocytosis of Ellipsoidal Nanoparticles
por: Zhang, Yudie, et al.
Publicado: (2021) -
Polyethylene glycol–polylactic acid nanoparticles modified with cysteine–arginine–glutamic acid–lysine–alanine fibrin-homing peptide for glioblastoma therapy by enhanced retention effect
por: Wu, Junzhu, et al.
Publicado: (2014) -
Pretreatment with chemotherapeutics for enhanced nanoparticles accumulation in tumor: the potential role of G2 cycle retention effect
por: Gao, Huile, et al.
Publicado: (2014) -
Effects of ligand distribution on receptor-diffusion-mediated cellular uptake of nanoparticles
por: Li, Long, et al.
Publicado: (2017)